465.86

0.10% 0.48

Pre-market: 465.86

Medpace Holdings Inc (MEDP)

Overview News Price History Option Chain Financials Discussions Forecast

Medpace Holdings Inc stock is traded at $465.86, with a volume of 374.55K. It is up +0.10% in the last 24 hours and down -17.04% over the past month. Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Previous Close:

$465.38

Open:

$465.38

24h Volume:

374.55K

Relative Volume:

1.22

Market Cap:

$13.22B

Revenue:

$2.36B

Net Income/Loss:

$433.01M

P/E Ratio:

32.58

EPS:

14.2984

Net Cash Flow:

$676.77M

1W Performance:

+6.34%

1M Performance:

-17.04%

6M Performance:

-3.42%

1Y Performance:

+43.61%

1-Day Range:

$460.90

$473.20

1-Week Range:

$435.77

$473.20

52-Week Range:

$250.05

$628.92

Medpace Holdings Inc Stock (MEDP) Company Profile

Name

Medpace Holdings Inc

Sector

Healthcare (1106)

Industry

Diagnostics & Research (52)

Phone

(513) 579-9911

Address

5375 MEDPACE WAY, CINCINNATI, OH

Employee

6,200

Twitter

@WorkatMedpace

Next Earnings Date

2025-10-22

Latest SEC Filings

MEDP's Discussions on Twitter

Compare MEDP vs TMO, DHR, IDXX, A, WAT

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MEDP Medpace Holdings Inc	465.86	13.21B	2.36B	433.01M	676.77M	14.30
TMO Thermo Fisher Scientific Inc	512.69	190.90B	44.56B	6.73B	6.29B	17.74
DHR Danaher Corp	204.73	144.26B	24.57B	3.60B	5.26B	5.051
IDXX Idexx Laboratories Inc	648.70	50.60B	4.30B	1.06B	1.04B	13.08
A Agilent Technologies Inc	120.54	33.67B	6.95B	1.30B	1.15B	4.5696
WAT Waters Corp	319.04	30.62B	3.17B	642.63M	516.49M	10.77

Medpace Holdings Inc Stock (MEDP) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-18-26	Upgrade	TD Cowen	Sell → Hold
Feb-13-26	Upgrade	Jefferies	Hold → Buy
Feb-10-26	Upgrade	Robert W. Baird	Neutral → Outperform
Nov-13-25	Initiated	BMO Capital Markets	Market Perform
Oct-02-25	Downgrade	Barclays	Equal Weight → Underweight
Sep-03-25	Downgrade	Rothschild & Co Redburn	Buy → Neutral
Jul-29-25	Downgrade	UBS	Neutral → Sell
Jul-23-25	Downgrade	TD Cowen	Hold → Sell
Jun-24-25	Initiated	Barclays	Equal Weight
Apr-22-25	Downgrade	William Blair	Outperform → Mkt Perform
Apr-14-25	Downgrade	TD Cowen	Buy → Hold
Mar-24-25	Initiated	Leerink Partners	Market Perform
Oct-23-24	Downgrade	Robert W. Baird	Outperform → Neutral
Oct-14-24	Initiated	Redburn Atlantic	Buy
Sep-27-24	Downgrade	UBS	Buy → Neutral
Sep-25-24	Downgrade	Jefferies	Buy → Hold
Aug-01-24	Initiated	Truist	Hold
May-29-24	Initiated	TD Cowen	Buy
May-28-24	Initiated	Mizuho	Buy
Apr-23-24	Upgrade	Jefferies	Hold → Buy
Mar-18-24	Initiated	Deutsche Bank	Hold
Feb-15-24	Upgrade	UBS	Neutral → Buy
Oct-24-23	Upgrade	Robert W. Baird	Neutral → Outperform
May-08-23	Upgrade	Guggenheim	Neutral → Buy
Oct-27-22	Upgrade	UBS	Sell → Neutral
Sep-07-22	Initiated	UBS	Sell
May-24-22	Initiated	Guggenheim	Neutral
Aug-05-21	Resumed	Credit Suisse	Outperform
Oct-02-20	Upgrade	Truist	Hold → Buy
Jun-08-20	Upgrade	Robert W. Baird	Underperform → Neutral
May-13-20	Downgrade	Wolfe Research	Outperform → Peer Perform
Apr-30-20	Upgrade	SunTrust	Sell → Hold
Apr-20-20	Downgrade	Robert W. Baird	Neutral → Underperform
Mar-17-20	Downgrade	SunTrust	Hold → Sell
Jan-27-20	Downgrade	SunTrust	Buy → Hold
Oct-31-18	Upgrade	SunTrust	Hold → Buy
Sep-17-18	Initiated	SunTrust	Hold
Jul-31-18	Upgrade	William Blair	Mkt Perform → Outperform
Nov-01-17	Downgrade	William Blair	Outperform → Mkt Perform
Sep-29-17	Initiated	Raymond James	Mkt Perform
Jul-10-17	Downgrade	KeyBanc Capital Mkts	Overweight → Sector Weight

View All

Medpace Holdings Inc Stock (MEDP) Latest News

06:25 AM

Focus Partners Advisor Solutions LLC Grows Stock Position in Medpace Holdings, Inc. $MEDP - MarketBeat

06:25 AM

Mar 04, 2026

Royal Bank Of Canada Upgrades Medpace (NASDAQ:MEDP) to Moderate Buy - MarketBeat

Mar 04, 2026

CI Investments Inc. Sells 5,860 Shares of Medpace Holdings, Inc. $MEDP - MarketBeat

Mar 04, 2026

Mar 03, 2026

7 Analysts Assess Medpace Holdings: What You Need To Know - Benzinga

Mar 03, 2026

MEDPMedpace Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Results - ADVFN Ltd

Mar 03, 2026

Medpace is Differentiated as Most Efficient Contract Research Organization, RBC Says - marketscreener.com

Mar 03, 2026

Medpace (NASDAQ:MEDP) Earns Outperform Rating from Analysts at Royal Bank Of Canada - MarketBeat

Mar 03, 2026

Fisher Asset Management LLC Purchases 12,399 Shares of Medpace Holdings, Inc. $MEDP - MarketBeat

Mar 03, 2026

RBC Initiates Medpace Holdings at Outperform With $522 Price Target - marketscreener.com

Mar 03, 2026

RBC Capital initiates Medpace stock with Outperform rating By Investing.com - Investing.com Canada

Mar 03, 2026

RBC Capital initiates Medpace stock with Outperform rating - Investing.com India

Mar 03, 2026

Mar 02, 2026

Medpace (NASDAQ:MEDP): Strongest Q4 Results from the Drug Development Inputs & Services Group - Yahoo Finance

Mar 02, 2026